Back to search

France· FR:60144119

KAPRUVIA 50 microgrammes/mL, solution injectable

A difelikefalin product containing acétate de difélikéfaline, registered in France by VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE. The same ATC class is registered in 14 of our 19 countries.

ATC V03AX04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedKAPRUVIA 50 microgrammes/mL, solution…ATCV03AX04REGISTER NO.FR:60144119PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Difelikefalin is registered in 14 of 19 countries.

Countries holding a registration under ATC V03AX04 (difelikefalin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Difelikefalin · ATC V03AX04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE DE DIFÉLIKÉFALINE
Manufacturer
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
Country
France (FR)
ATC code
V03AX04
ATC class
Difelikefalin
Defined daily dose
15 mcg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955089650
    12 flacon(s) en verre de 1 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2303eecf-6446-468a-95df-fec901775bc4
GET /v1/drugs/2303eecf-6446-468a-95df-fec901775bc4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60144119",
  "date_amm": "2022-04-25",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/22/1643",
  "substance": "ACÉTATE DE DIFÉLIKÉFALINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about difelikefalin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.